Gliomatosis cerebri: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
No edit summary
Line 30: Line 30:
</div>
</div>


[[Category:Disease state]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Oncology]]
[[Category:Oncology]]

Revision as of 22:03, 28 July 2011

For patient information click here.

Gliomatosis cerebri
ICD-O: 9381/3
MeSH D018302

WikiDoc Resources for Gliomatosis cerebri

Articles

Most recent articles on Gliomatosis cerebri

Most cited articles on Gliomatosis cerebri

Review articles on Gliomatosis cerebri

Articles on Gliomatosis cerebri in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Gliomatosis cerebri

Images of Gliomatosis cerebri

Photos of Gliomatosis cerebri

Podcasts & MP3s on Gliomatosis cerebri

Videos on Gliomatosis cerebri

Evidence Based Medicine

Cochrane Collaboration on Gliomatosis cerebri

Bandolier on Gliomatosis cerebri

TRIP on Gliomatosis cerebri

Clinical Trials

Ongoing Trials on Gliomatosis cerebri at Clinical Trials.gov

Trial results on Gliomatosis cerebri

Clinical Trials on Gliomatosis cerebri at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Gliomatosis cerebri

NICE Guidance on Gliomatosis cerebri

NHS PRODIGY Guidance

FDA on Gliomatosis cerebri

CDC on Gliomatosis cerebri

Books

Books on Gliomatosis cerebri

News

Gliomatosis cerebri in the news

Be alerted to news on Gliomatosis cerebri

News trends on Gliomatosis cerebri

Commentary

Blogs on Gliomatosis cerebri

Definitions

Definitions of Gliomatosis cerebri

Patient Resources / Community

Patient resources on Gliomatosis cerebri

Discussion groups on Gliomatosis cerebri

Patient Handouts on Gliomatosis cerebri

Directions to Hospitals Treating Gliomatosis cerebri

Risk calculators and risk factors for Gliomatosis cerebri

Healthcare Provider Resources

Symptoms of Gliomatosis cerebri

Causes & Risk Factors for Gliomatosis cerebri

Diagnostic studies for Gliomatosis cerebri

Treatment of Gliomatosis cerebri

Continuing Medical Education (CME)

CME Programs on Gliomatosis cerebri

International

Gliomatosis cerebri en Espanol

Gliomatosis cerebri en Francais

Business

Gliomatosis cerebri in the Marketplace

Patents on Gliomatosis cerebri

Experimental / Informatics

List of terms related to Gliomatosis cerebri

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Gliomatosis cerebri (infiltrative diffuse astrocytosis) is a rare primary brain tumor. It is commonly characterized by diffuse infiltration of the brain with neoplastic glial cells that affect various areas of the cerebral lobes[1].

While gliomatosis cerebri can occur at any age, it is generally found in the third and fourth decades of life. It may affect any part of the brain or even the spinal cord, optic nerve and compact white matter. Clinical manifestations are indefinite, and include headache, seizures, visual disturbances, corticospinal tract deficits, lethargy, and dementia.

Before the advent of MRI, diagnosis was generally not established until autopsy. Even with MRI, however, diagnosis is difficult.[2] Typically, gliomatosis cerebri appears as a diffuse, poorly circumscribed, infiltrating non-enhancing lesion that is hyperintense on T2-weighted images and expands the cerebral white matter. It is difficult to distinguish from highly infiltrate anaplastic astrocytoma or GBM.[3] The prognosis for gliomatosis cerebri is generally poor, with a median survival time of only 12 months.[4] Surgery is not practical considering the extent of the disease, standard chemotherapy (nitrosourea) has been unsuccessful, and while brain irradiation can stabilize or improve neurologic function in some patients, its impact on survival has yet to be proven.[citation needed]

Notes

Template:Nervous tissue tumors Template:SIB de:Gliomatosis cerebri

Template:WikiDoc Sources